Connect with us
courtesy of time.com High Demand for RSV Medication Causes Shortage A recently approved treatment for Respiratory Syncytial Virus (RSV) is facing a shortage as demand outpaces...
courtesy of kffhealthnews.org Introduction A new therapy called nirsevimab, approved by the CDC to protect infants from the respiratory syncytial virus (RSV), has left parents scrambling...
Recent Comments